KPTA calls for well-prepared drug policy in KORUS talks

Published: 2006-10-26 06:59:00

Updated: 2006-10-26 06:59:00

The Korea Pharmaceutical Manufacturers Association (KPMA) has urged the government to establish more well-prepared drug measure in the ongoing free trade agreement (FTA) talks with the United States, as the government's new drug measure will ultimately bring negative effects for Korean patients. ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK